Interview with Alina Culcea, Managing Director, Actavis Romania
We understand that you already took over the reins at Actavis as interim GM in late 2009, before being officially appointed a few months later in 2010. What have been…
Address: Actavis Romania, Ion Mihalache Blvd. 11, sector 1, Bucharest 011 171, Romania
Tel: +40 21 351 45 67
Web: http://www.actavis.com.ro/ro/default.htm
Having joined Actavis Group in March 2006, the Romanian division strengthens the group’s oncology actavities. The Romanian branch embraces the Group’s center of excellence for the development, production and marketing of generic oncology medicines.
With a broad portfolio of oncology products, the company has a successful presence in a growing number of foreign markets. The latest market within the portfolio are in the United States and Japan, where since 2008, the company sells oncology products manufactured in the production unit in Bucharest – Sindan Pharma, a company previously acquired by Actavis Group in 2006.
Actavis offers its customers the broadest product portfolio and the most advanced production line of generic drugs. Currently, Actavis sells over 830 products (over 10,000 SKUs) in hospitals and pharmacies around the world, covering all relevant therapeutic areas. In 2008, the Company has launched over 660 products (235 molecules) and for 2009 it is expected that number to rise to 800 launches of new products.
We understand that you already took over the reins at Actavis as interim GM in late 2009, before being officially appointed a few months later in 2010. What have been…
The country manager of a leading specialty care bio-business reveals how the economic and geo-social fundamentals in Romania are highly attractive from an innovative pharmaceutical producer standpoint. He speaks about…
The longstanding GM of one of the foremost data management services companies for Romanian healthcare analyses some of the key trends sweeping the industry while at he same time outlining…
The founder of the group explains how the pharmacy chain has become a regional trailblazer by redefining the concept of ‘neighborhood pharmacy’ along the principles of being cheap, near and…
The association’s longtime executive director outlines the opportunities and challenges for generics companies in the Romanian market. Analyzing in depth the local market regulatory landscape, he proposes modifications to the…
One of the new generation of pharmaceutical general managers in Romania discusses the complexities of introducing innovative therapies on the market and explains how the country has become the ‘to-go-to’…
One of the so-called ‘new generation’ of pharmaceutical GMs in Romania outlines his first impressions of the local market and details how MSD has managed to shape in-county developments in…
The GM of one of the leading generics companies on the Romanian market shares insights into why generics penetration remains underdeveloped and the importance of having an export strategy and…
The president of the association representing clinical research organisations speaks out about Romania’s attractiveness as a destination country in an era of clinical research globalisation. He further sheds ideas on…
With a history dating back to 1668, Merck is obviously well established as the oldest pharmaceutical and chemical company in the world. Of course, we are interested in knowing how…
APMGR is obviously a rather young association that has only really been active since about a year now. Can you first comment on the timing that the Association was called…
Under various former names for over five decades, the Agency has undoubtedly played a key role in setting a regulatory framework for Romania’s pharmaceutical market. Over these five decades, thorough…
To start off, we see that you have been with Cegedim Romania for 10 years, after running your own business initially. What would you say have been your main milestones…
See our Cookie Privacy Policy Here
